H. Lawrence Remmel - Net Worth and Insider Trading
H. Lawrence Remmel Net Worth
The estimated net worth of H. Lawrence Remmel is at least $380 dollars as of 2024-09-20. H. Lawrence Remmel is the Director of Atossa Therapeutics Inc and owns about 260 shares of Atossa Therapeutics Inc (ATOS) stock worth over $380. Details can be seen in H. Lawrence Remmel's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that H. Lawrence Remmel has not made any transactions after 2017-04-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of H. Lawrence Remmel
H. Lawrence Remmel Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, H. Lawrence Remmel owns 1 companies in total, including Atossa Therapeutics Inc (ATOS) .
Click here to see the complete history of H. Lawrence Remmel’s form 4 insider trades.
Insider Ownership Summary of H. Lawrence Remmel
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ATOS | Atossa Therapeutics Inc | 2017-04-17 | director |
H. Lawrence Remmel Latest Holdings Summary
H. Lawrence Remmel currently owns a total of 1 stock. H. Lawrence Remmel owns 260 shares of Atossa Therapeutics Inc (ATOS) as of April 17, 2017, with a value of $380.
Latest Holdings of H. Lawrence Remmel
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ATOS | Atossa Therapeutics Inc | 2017-04-17 | 260 | 1.46 | 380 |
Holding Weightings of H. Lawrence Remmel
H. Lawrence Remmel Form 4 Trading Tracker
According to the SEC Form 4 filings, H. Lawrence Remmel has made a total of 0 transactions in Atossa Therapeutics Inc (ATOS) over the past 5 years. The most-recent trade in Atossa Therapeutics Inc is the acquisition of 208 shares on April 17, 2017, which cost H. Lawrence Remmel around $1,575.
Insider Trading History of H. Lawrence Remmel
- 1
H. Lawrence Remmel Trading Performance
GuruFocus tracks the stock performance after each of H. Lawrence Remmel's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by H. Lawrence Remmel is 4.03%. GuruFocus also compares H. Lawrence Remmel's trading performance to market benchmark return within the same time period. The performance of stocks bought by H. Lawrence Remmel within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how H. Lawrence Remmel's insider trading performs compared to the benchmark.
Performance of H. Lawrence Remmel
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 8.5 | | | | | |
| Relative Return to S&P 500(%) | 7.67 | | | | | |
H. Lawrence Remmel Ownership Network
H. Lawrence Remmel Owned Company Details
What does Atossa Therapeutics Inc do?
Who are the key executives at Atossa Therapeutics Inc?
H. Lawrence Remmel is the director of Atossa Therapeutics Inc. Other key executives at Atossa Therapeutics Inc include SVP & Finance and Accounting Heather Rees , CFO & General Counsel Kyle Guse , and director & 10 percent owner & Chief Scientific Officer Shu-chih Chen .
Atossa Therapeutics Inc (ATOS) Insider Trades Summary
Over the past 18 months, H. Lawrence Remmel made no insider transaction in Atossa Therapeutics Inc (ATOS). Other recent insider transactions involving Atossa Therapeutics Inc (ATOS) include a net sale of 0 shares made by Gregory L Weaver , and a net purchase of 25,000 shares made by Jonathan Finn .
In summary, during the past 3 months, insiders sold 0 shares of Atossa Therapeutics Inc (ATOS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 50,000 shares of Atossa Therapeutics Inc (ATOS) were sold and 75,000 shares were bought by its insiders, resulting in a net purchase of 25,000 shares.
Atossa Therapeutics Inc (ATOS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Atossa Therapeutics Inc Insider Transactions
H. Lawrence Remmel Mailing Address
Above is the net worth, insider trading, and ownership report for H. Lawrence Remmel. You might contact H. Lawrence Remmel via mailing address: C/o Atossa Genetics, Inc., 4105 Madison Street, Suite 320, Seattle Wa 98112.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
